PainChek signs landmark deal with aged care provider
SINGAPORE: Australian medical device company PainChek (ASX: PCK) has advanced its international expansion strategy with receipt of a key regulatory clearance from Singapore’s Health Sciences Authority and the subsequent signing of a landmark commercial agreement with the country’s leading aged care provider Allium Healthcare Holdings.
The two-year licencing deal will see PainChek’s smart phone-based pain assessment and monitoring application employed by Allium across its network of nursing homes, providing staff with the capacity to better assess and quantify patient pain levels and enhance treatment plans.
The app will also be integrated into Allium’s homecare packages offered to elderly patients living at home with dementia and communication difficulties.
The agreement signals PainChek’s foray into Singapore and provides a springboard for entry into the broader Asian market with its large ageing population.
According to a 2015 study by Singapore’s Institute of Mental Health, one in 10 Singapore residents aged 60 and above may have dementia, translating to almost 82,000 people in 2018 and expected to exceed 100,000 in a few years’ time.






